Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Fuisz Announces a New Lozenge Product to Enhance E-cigarette Tobacco Satisfaction As Well As THC Delivery From Medical Marijuana

MIAMI, Jan. 8, 2013 /PRNewswire/ -- Fuisz LLC today announced that it will launch a new oral pre-product in the form of a lozenge in early 2013 designed to enhance tobacco satisfaction from electronic cigarettes, as well as to enhance THC absorption from medical marijuana.   The product is protected by a patent pending.

Joseph Fuisz, Managing Member of Fuisz, commented, "The extraordinary growth in electronic cigarette consumption at the expense of conventional cigarettes is perceived as large net positive for public health.  However, the e-cigarette industry is still struggling to enhance tobacco satisfaction from what is essentially a buccal delivery product.  That means that nicotine absorption is occurring across the oral mucosa in the mouth as opposed to the lung.  As a result, the nicotine levels delivered by an e-cigarette are much lower (Cmax) and slower to build (Tmax) than the nicotine levels delivered by a traditional cigarette.  Our new oral dosage unit contains a number of agents designed to enhance the speed and level of tobacco satisfaction from the electronic cigarette. Best of all, the product works dramatically."

Mr. Joseph Fuisz continued:  "Our lozenge product itself contains no tobacco, nicotine or other active drug ingredient. We intend to market our product under our own trade name – to be announced -- through conventional retail channels."

Dr. Richard Fuisz (http://en.wikipedia.org/wiki/Richard_Fuisz), Fuisz founder, remarked: "We have invented and developed an oral pre-product which is easy and pleasant to use, and enhances delivery for medical marijuana users who vaporize their material. The user simply uses the pre-product while vaporizing the medical marijuana. Consistent with the macro trend in pharmaceutical drug delivery toward more effective smaller dosing, this advance allows for lower dosing with the same medicinal effect from a lesser amount of vaporized THC. The growth of medical marijuana, and in particular the growth of vaporization of medical marijuana has been recognized by global authorities including Health Canada to result in a smaller toxicant profile than the conventional smoking of marijuana, and hence the need to maximize its efficiency."

Fuisz LLC is a private technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology and diagnostic applications. Fuisz has extensive experience working with big and specialty pharma, as well as large consumer products companies. Fuisz has its headquarters in Miami. www.fuisz.com

SOURCE Fuisz LLC

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
We often get asked “Should I use GridFS for file storage with MongoDB”. As with most things, the answer is a staunch “it depends”. GridFS looks like a great idea on paper - a virtual filesystem held within MongoDB which allows for larger than 16MB files to be held, synced and replicat...
The supply chain is evolving, and buyers need to analyze and predict, but also to manage risk. When Capgemini's business information management (BIM) practices unit needed to provide big data capabilities to its insurance company customers, it needed to deliver the right information t...
Some people believe good or bad things always happen in threes. I believe you will always be able to find three (and probably more) things that are good or bad and somewhat related, but sometimes I get surprised by the apparent coincidental appearance of several closely related “things...
This article defines long polling and presents a few techniques on how long polling could be used in Spring MVC web applications. Discussion covers both the AJAX and the server part of the solution as well as outlines a few possible options for implementation. The article compares perf...
Red Hat, Inc., on Wednesday announced that it has signed a definitive agreement to acquire eNovance, a provider of open source cloud computing services. Combined with Red Hat’s existing leadership in OpenStack, the addition of eNovance’s systems integration capabilities and engineering...
Hear from Red Hat leaders and industry experts on Tuesday, June 10, 2014, at 11am and see how Red Hat Enterprise Linux continues to deliver unmatched customer value, increased efficiency, and true strategic advantage for global customers across every industry. Attendees will learn mor...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE